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ABSTRACT
Background: Asthma patient education has been recognized as an important component of asthma control.
The aim of the present study was to carry out a cost-effectiveness analysis of patient education in patients with
mild to moderate asthma during 6 months of follow up.
Methods: We randomly allocated asthma patients who were covered by health insurance to a control group
(group C) or a self-management group (group S). Self-management consisted of measurement of peak expira-
tory flow (PEF) and monthly individual education and advice by a specialist. Effectiveness was evaluated on
the basis of PEF, quality of life, and mean total cost of medical expenses. Furthermore, we asked the patients
about symptom improvement and their level of satisfaction with this program.
Results: PEF values in group S gradually increased at 3 months after the self-management program and re-
mained at high levels. The total costs decreased by 30% from baseline in group S, whereas they increased by
15% in group C. The cost of one-day visits showed no difference between the two groups, but the frequency of
visits to general practitioners decreased in group S as compared with group C. Furthermore, the number of epi-
sodes of asthma attacks decreased in group S but not in group C, and 94% of the group S patients replied that
they considered the self-management program to have been useful.
Conclusions: We conclude that an individual self-management program is not only a safe and effective aid in
the treatment of mild to moderate asthma but can also reduce medical expenses.
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INTRODUCTION
Asthma occurs in 3% of the adult population and 6% of
children in Japan, and there is evidence that the inci-
dence is increasing. The annual cost for asthma pa-
tients during the past 10 years is estimated at 302 to
450 billion yen. Because asthma is a chronic respira-
tory disease and the costs are largely due to the con-
sequences of uncontrolled disease , it is presumed
that the costs could be reduced if asthma control is
improved.1 Therefore, health economical evaluations
may be strongly warranted.2,3 Asthma patient educa-
tion has been recommended in several clinical guide-
lines.4,5 To achieve the ultimate goals of such guide-
lines, patients need to be able to manage their condi-
tions on their own more safely. It was reported that
12-month asthma education programs improved qual-
ity of life, level of pulmonary function, and compli-
ance with inhaled corticosteroid treatment.6
However, previous cost-effectiveness assessments
after asthma education are rare and of limited applica-
bility to clinical practice . Gallefoss et al. 7 reported
that one-year self-management of asthma increased
forced expiratory volume in one second (FEV1) and
reduced costs . In the present trial , to determine
whether short-term self-management programs are
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26 ± 2025 ± 16Age
11/1015/7Adult/children
11/1014/8Male/female
0.96 ± 0.860.96 ± 0.77Frequencies of clinic visits (time/M)
87Inhaled corticosteroids
Al data are expressed as means ± SEM.
Table 1 Baseline characteristics of the asthma patients in this study
also effective in improving pulmonary function and
asthma symptoms and reducing cost, we conducted a
randomized parallel-group study in patients with mild
to moderate asthma.
METHODS
PATIENTS
This study was a randomized, parallel-group, prospec-
tive trial. The study population was recruited between
February and July 2003. We extracted patients with
mild to moderate asthma diagnosed according to the
criteria of the Asthma Prevention and Management
Guidelines, Japan (JGL, 2003)8 who had been treated
by general practitioners (GP) from the receipts of the
Japan Health Insurance Society. They were all invited
by mail to participate in a self-management trial. Of
114 asthma patients recruited, 4 who refused to par-
ticipate afterwards and 67 who discontinued submit-
ting the diary within 4 weeks were excluded from the
study. The remaining 43 subjects were thus enrolled
in the study. The inclusion criteria were as follows:
age 6 to 67 years, asthma severity mild to moderate
according to the JGL, 2003.8 Patients younger than 6
years were excluded because it was difficult for them
to use the peak flow meter correctly.
SELF-MANAGEMENT PROGRAM
None of the randomized patients had previously re-
ceived any organized asthma education. The 43 sub-
jects were randomized into a self-management group
(group S) and a control group (group C). The group
S patients were given an AirZone peak expiratory
flow (PEF) meter (Matsuyoshi & Co., Ltd, Tokyo, Ja-
pan) and were given a booklet with instructions on its
correct use. At the beginning of this program, all pa-
tients continued the treatment they had been receiv-
ing.
All patients received a diary in which to register
their asthma symptoms ( both daytime and night-
time), medication use, and twice daily PEF measure-
ments (morning and evening), and submitted the di-
ary once a week. The PEF values were compared
with the baseline values at 4, 8, 12, 18 and 24 weeks
after the start of the self-management program .
Those belonging to group S also received a booklet in
which the pathophysiology of asthma , the role of
asthma medication and side effects, allergic and non-
allergic triggers , and symptoms indicating an im-
pending exacerbation were described. The personal
best peak flow value was defined as the highest morn-
ing prebronchodilator PEF measurement as recorded
in the 4-week diary. The patients were provided with
a 3-zone (green : 80― 100% of personal best value
(PBV), yellow: 60―80% PBV, and red: <60% PBV) self-
management plan, based on symptoms and morning
prebronchodilator PEF . 8 In the case of the green
zone, we advised patients to continue maintenance
treatment or reduce their medication if the PEF val-
ues remained in the green zone for more than 3
months. If the PEF values went down to the yellow
zone, we asked patients to increase the dosage of the
controller medicine or to take reliever medicine. If pa-
tients whose PEF values were in the red zone had
continued asthma symptoms in spite of bronchodila-
tor therapy, we advised them to consult a GP or other
physician promptly. All subjects were encouraged to
ask questions about personal matters related to their
disease. Furthermore, we assessed the frequency of
asthma exacerbations during the trial. Exacerbations
were defined as episodes which required admission
to the hospital, emergency room visits andor intra-
venous administration of bronchodilators and we
compared the frequency before and after 24 weeks of
the trial.
COSTS
Medical expenses consist of direct costs borne by the
health care system, community, and family, and indi-
rect costs, which are defined as productivity loss and
time costs borne by the individual, family, and society
or by the employer. In this study, we examined direct
costs based on the actual expenses related to GP con-
sultations including the costs of emergency clinic vis-
its and pharmaceuticals . Any expenses related to
other diseases were excluded , but pharmaceutical
costs associated with asthma exacerbations were in-
cluded.
QUESTIONNAIRE
We asked the patients about symptom improvement
and their level of satisfaction with this program. The
questionnaire items were as follows: 1) Was this pro-
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Fig. 1 Changes in peak expiratory flow (PEF) from base-
line values in the self-management group (group S). Data 
are expressed as means ± SEM.
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Fig. 2 Direct costs of asthma per month in the control 
group (group C, open columns) and self-management group 
(group S, shaded columns). Data are expressed as means  
± SEM.
Fig. 3 Number of visits to general practitioners in the con-
trol group (group C, open columns) and self-management 
group (group S, shaded columns). Data are expressed as 
means ± SEM. *P＜0.01, significantly diferent from data 
before the trial.
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Fig. 4 Percentage of patients who experienced asthma 
exacerbations in the control group (group C, open col-
umns) and self-management group (group S, shaded 
columns). *P＜0.05, significantly diferent from data before 
the trial.
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gram useful for you? 2) Could you understand your
asthma condition? 3) Did your knowledge of asthma
increase? 4) Did you like this program？
STATISTICAL ANALYSIS
All values were expressed as means ± SEM. Analyses
within and between groups were performed by t-test
and P-values less than 0.05 were considered to indi-
cate statistically significant differences.
RESULTS
SUBJECTS
Among the asthma patients enrolled, 27% of children
and 56% of adults continued to measure the PEF for 6
months. Thus, the number of patients analyzed at the
end of the study was 21 in group S and 22 in group C.
The patients’ characteristics are shown in Table 1.
There were no significant differences in the distribu-
tion of age , gender or treatment of inhaled corti-
costeroids between the two groups.
PULMONARY FUNCTION
As shown in Figure 1, the PEF values in group S in-
creased from 353 ± 44 lmin at baseline to 384 ± 38 l
min, which corresponded to a 9.3% increase at 3
months after the start of the self-management pro-
gram, and the values remained at high levels until 6
months.
COSTS
Direct costs per month were not significantly differ-
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Fig. 5 Questionnaire administered to group S patients about their self-manage-
ment program. N.D.: not described.
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no
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good N.D.
Could you understand your
condition?
Did you increase knowledge
of asthma?
Do you like this program?
ent between the two groups at the start of the study
(group S; 9650 yen vs. group C; 8770 yen) . Mean
costs from March 2003 to June 2003 decreased by
30% in group S, whereas they increased by 15% in
group C (Fig. 2). Although there was no statistically
significant difference between the changes in the two
groups (p = 0.058 ) , the self-management group
showed a tendency toward a decrease in total costs.
The costs per visit were not significantly different be-
tween the two groups, but the frequency of visits to
general practitioners showed a significantly larger de-
crease in group S than in group C (0.79 to 0.67 vs.
0.95 to 0.99month, respectively, p = 0.012)(Fig. 3).
During the self-management period , significant re-
ductions in the frequency of emergency room visits
and admissions due to exacerbation of asthma were
noted in group S (Fig. 4).
QUESTIONNAIRE
Figure 5 shows the results of the questionnaire on
this self-management program in group S. 94% of pa-
tients found the program“very useful”or“useful”,
whereas 6% found it“non-useful”. Furthermore, large
numbers of patients responded that they could under-
stand their asthma condition ( 83% ) , obtained in-
creased knowledge of the disease (72%), and liked
the self-management program (78%).
DISCUSSION
The present study demonstrated that the self-
management program in mild to moderate asthma pa-
tients improved PEF and symptoms and at the same
time decreased costs . These results are in accord
with those of a previous study by Gallefoss et al. 7
showing that patient education in mild to moderate
asthma patients in a 12-month follow-up study im-
proved quality of life and saved costs. On the other
hand , self-management programs are not of addi-
tional benefit in all phenotypes of asthma.9 For exam-
ple, self-management programs may not provide sub-
stantial improvements in the clinical outcomes in pa-
tients with very severe asthma or well-controlled
asthma, and patients already on relatively high doses
of inhaled corticosteroids.
The PEF is widely used as an objective index of air-
way narrowing, but most of the patients in this study
did not know about the PEF before participating in
this program. In our study, PEF measurement com-
pliance was 56% in the adults compared with 27.3% in
the children. This difference is probably due to the
difficulty for children to measure the PEF consis-
tently , and it seems important to have the under-
standing and cooperation of their parents . Cote
et al.10 reported that compliance with PEF measure-
ments was relatively good during the first month
(63%) but fell to 50% at 6 months. These findings are
consistent with those of our study. During the self-
management program, the PEF values in group S in-
creased at 3 months and remained at high levels
thereafter. The reason for this is not clear, but one
possibility is that the likelihood of forgetting to take
medicine decreased because the patients were asked
to keep diaries everyday. In addition, it seems very
important for patients to understand the signs which
suggest the worsening of their asthma condition. The
patients in group S were satisfied with this self-
management program. It was surprising that there
were several patients who had never been taught
about asthma control and treatment by their GP. In
this program, it would be effective to have monthly
consultations with each patient tailored to their indi-
vidual problems, thereby providing an opportunity for
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patients to express their fears and concerns.
The mean costs from March to June 2003 de-
creased by 30% in group S, whereas they increased
by 15% in group C. On the other hand, the costs per
visit were not significantly different between the two
groups . Therefore , the decrease in total costs in
group S appears to result from a lower frequency of
visits to GPs.
The total costs of asthma are rising as the number
of asthma patients increases. Anti-inflammatory ther-
apy with inhaled corticosteroids has markedly re-
lieved asthma symptoms and provided better control
of asthma worldwide. In consequence, the costs of
asthma has decreased in Western countries. A recent
report on cost-effectiveness and cost-benefit analyses
revealed that for high-cost patients , PEF-based
asthma education with a self-management program
was the most cost-effective alternative in reducing
costs associated with emergency visits and hospitali-
zations due to asthma exacerbations.11
The Global Initiative for Asthma 2002 ( GINA )
guidelines,12 the first section of which covers patient
education, states that the key point of patient educa-
tion is self-management . However , under the Japa-
nese health insurance system, it is difficult to intro-
duce such programs because there is not enough
time to devote to patient education , and because
there is no medical treatment fee system for such
programs.
In this study, we investigated the direct costs of
asthma and, in contrast, other reports showed that
the indirect costs of asthma were significantly higher
in the control group than in the intervention group.13
It is important to analyze both direct and indirect
costs , but indirect costs have not been sufficiently
evaluated in Japan. Better control of asthma results in
reduced absence from work due to asthma attacks
and mortality due to asthma, and consequently fewer
severe asthma patients and thus decreases indirect
medical expenses.
In conclusion , the self-management program for
patients with mild to moderate asthma was shown in
a 6-month follow-up to be a safe and effective means
of improving asthma symptoms and reducing the fre-
quency of asthma exacerbations, which may result in
decreased costs . Further long-term studies will be
needed to determine the long-term role of self-
management programs.
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